{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:33:45Z","timestamp":1724805225234},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.medcli.2015.05.009","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T02:26:53Z","timestamp":1436840813000},"page":"67-68","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hiperuricemia y gota: impacto de la ecograf\u00eda"],"prefix":"10.1016","volume":"146","author":[{"given":"Juan","family":"Garc\u00eda Puig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2015.05.009_bib0155","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/15257770802138582","article-title":"Serum urate, metabolic syndrome and cardiovascular risk factors. A population-based study","volume":"27","author":"Puig","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.medcli.2015.05.009_bib0160","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2015.05.009_bib0165","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1136\/annrheumdis-2013-204647","article-title":"The global burden of gout: Estimates from the Global Burden of Disease 2010 study","volume":"73","author":"Smith","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2015.05.009_bib0170","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archinte.165.7.742","article-title":"Obesity, weight change, hypertension, diuretic use, and risk of gout in men: The Health Professionals Follow-up Study","volume":"165","author":"Choi","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medcli.2015.05.009_bib0175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.23245","article-title":"Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: The Third National Health and Nutrition Examination Survey","volume":"59","author":"Choi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2015.05.009_bib0180","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.metabol.2011.08.005","article-title":"Uric acid excretion in healthy subjects: A nomogram to assess the mechanisms underlying purine metabolic disorders","volume":"61","author":"Puig","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.medcli.2015.05.009_bib0185","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3899\/jrheum.140126","article-title":"Tubular urate transporter gene polymorphisms discriminate patients with gout who have normal and decreased urinary uric acid excretion","volume":"41","author":"Torres","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2015.05.009_bib0190","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun."},{"key":"10.1016\/j.medcli.2015.05.009_bib0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/15257770.2013.854902","article-title":"ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion","volume":"33","author":"Takada","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.medcli.2015.05.009_bib0200","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.numecd.2007.02.011","article-title":"Uric acid and oxidative stress: Relative impact on cardiovascular risk","volume":"17","author":"Strazzullo","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.medcli.2015.05.009_bib0205","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2015.05.009_bib0210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1001124","article-title":"Clinical practice: Gout","volume":"364","author":"Neogi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2015.05.009_bib0215","doi-asserted-by":"crossref","unstructured":"Grainger R, Dalbeth N, Keen H, Durcan L, Edwards NL, Perez-Ruiz F, et al. Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group. J Rheumatol. 2015. pii: jrheum.141164. [Epub ahead of print].","DOI":"10.3899\/jrheum.141164"},{"key":"10.1016\/j.medcli.2015.05.009_bib0220","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nrrheum.2014.139","article-title":"Screening for hyperuricaemia and gout: A perspective and research agenda","volume":"10","author":"Stamp","year":"2014","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.medcli.2015.05.009_bib0225","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/15257770.2013.853785","article-title":"Metabolic syndrome in primary gout","volume":"33","author":"Gonz\u00e1lez-Senac","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.medcli.2015.05.009_bib0230","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/art.24612","article-title":"Hyperuricemia and risk of stroke: A systematic review and meta-analysis","volume":"61","author":"Kim","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2015.05.009_bib0235","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10067-014-2520-7","article-title":"The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort","volume":"33","author":"Duskin-Bitan","year":"2014","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.medcli.2015.05.009_bib0240","first-page":"1549","article-title":"Hyperuricemia and tissue monourate deposits: prospective therapeutic considerations","volume":"19","author":"P\u00e9rez-Ruiz","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.medcli.2015.05.009_bib0245","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.medcli.2015.05.009_bib0250","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gout arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.medcli.2015.05.009_bib0255","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2013-203325","article-title":"Multinational evidence-based recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative","volume":"73","author":"Sivera","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2015.05.009_bib0260","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/15257770802136040","article-title":"Asymptomatic hyperuricemia: Impact of ultrasonography","volume":"27","author":"Puig","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids."},{"key":"10.1016\/j.medcli.2015.05.009_bib0265","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar3223","article-title":"Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: An ultrasound controlled study","volume":"13","author":"Pineda","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.medcli.2015.05.009_bib0270","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/acr.20527","article-title":"Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition: Concordance between readers","volume":"63","author":"Howard","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.medcli.2015.05.009_bib0275","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2011.154997","article-title":"Diagnosis of gout in patients with asymptomatic hyperuricemia: A pilot study","volume":"71","author":"De Miguel","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2015.05.009_bib0280","first-page":"830","article-title":"Value of a short four-joint ultrasound test for gout diagnosis: A pilot study","volume":"30","author":"Peiteado","year":"2012","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2015.05.009_bib0285","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2012-202301","article-title":"A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia","volume":"72","author":"Chowalloor","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2015.05.009_bib0290","unstructured":"Peiteado D, Villalba A, Mart\u00edn-Mola E, de Miguel E. Reduction but not disappearance of Doppler signal after two years of treatment for gout. Do we need a more intensive treatment? Clin Exp Rheumatol. 2015;33:385-90"},{"key":"10.1016\/j.medcli.2015.05.009_bib0295","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.amjmed.2013.05.009","article-title":"Resolution of massive tophaceous gout with three urate-lowering drugs","volume":"126","author":"Mej\u00eda-Chew","year":"2013","journal-title":"Am J Med."},{"key":"10.1016\/j.medcli.2015.05.009_bib0300","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/15257770.2013.853786","article-title":"Efficacy and safety of a urate lowering regimen in primary gout","volume":"33","author":"Bail\u00e9n","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775315003024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775315003024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T05:49:06Z","timestamp":1566971346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775315003024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0025775315003024"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2015.05.009","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hiperuricemia y gota: impacto de la ecograf\u00eda","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2015.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}